(Q39705956)

14 September 2017

Idiopathic pulmonary fibrosis in patients younger than 50 years (English)

1 reference

idiopathic pulmonary fibrosis

14 September 2017

1 reference

1 reference

Hassan F Nadrous

1

1 reference

14 September 2017

Jeffrey L Myers

series ordinal

2

1 reference

14 September 2017

Paul A Decker

series ordinal

3

1 reference

14 September 2017

Jay H Ryu

series ordinal

4

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

14 September 2017

1 reference

14 September 2017

80

1 reference

14 September 2017

1

1 reference

14 September 2017

37-40

1 reference

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962955-8

Idiopathic pulmonary fibrosis: current concepts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962955-8

Bronchiolitis obliterans and usual interstitial pneumonia. A comparative clinicopathologic study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962955-8

Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962955-8

Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962955-8

Natural History and Treated Course of Usual and Desquamative Interstitial Pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962955-8

Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962955-8

Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962955-8

Idiopathic Pulmonary Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962955-8

Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962955-8

The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962955-8

Clinical significance of histological classification of idiopathic interstitial pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962955-8

Nonparametric Estimation from Incomplete Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962955-8

Idiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962955-8

Radiological versus histological diagnosis in UIP and NSIP: survival implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962955-8

Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962955-8

Adult familial cryptogenic fibrosing alveolitis in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962955-8

10.1016/S0025-6196(11)62955-8

7 January 2021

Identifiers

DOI

0 references

1 reference